BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 16724117)

  • 21. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated B cells express CD28/B7-independent costimulatory activity.
    Ding L; Shevach EM
    J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.
    Jenkins MK; Taylor PS; Norton SD; Urdahl KB
    J Immunol; 1991 Oct; 147(8):2461-6. PubMed ID: 1717561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions.
    Goldstein JS; Chen T; Brunswick M; Mostowsky H; Kozlowski S
    J Immunol; 1998 Apr; 160(7):3180-7. PubMed ID: 9531273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic science for the clinician 56: inducible T-cell costimulator--the world of costimulation gets more complicated…and interesting.
    Sigal LH
    J Clin Rheumatol; 2012 Jun; 18(4):212-6. PubMed ID: 22647859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
    Ding L; Shevach EM
    Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T Cells.
    Leitner J; Herndler-Brandstetter D; Zlabinger GJ; Grubeck-Loebenstein B; Steinberger P
    J Immunol; 2015 Jul; 195(2):477-87. PubMed ID: 26041540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation.
    Muraille E; De Smedt T; Thielemans K; Urbain J; Moser M; Leo O
    Cell Immunol; 1995 May; 162(2):315-20. PubMed ID: 7538050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloreactive gamma delta thymocytes utilize distinct costimulatory signals from peripheral T cells.
    Penninger JM; Timms E; Shahinian A; Jezo-Bremond A; Nishina H; Ionescu J; Hedrick SM; Mak TW
    J Immunol; 1995 Oct; 155(8):3847-55. PubMed ID: 7561091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors.
    Guerder S; Carding SR; Flavell RA
    J Immunol; 1995 Dec; 155(11):5167-74. PubMed ID: 7594526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The number of responding CD4 T cells and the dose of antigen conjointly determine the TH1/TH2 phenotype by modulating B7/CD28 interactions.
    Rudulier CD; McKinstry KK; Al-Yassin GA; Kroeger DR; Bretscher PA
    J Immunol; 2014 Jun; 192(11):5140-50. PubMed ID: 24752446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and distribution of the costimulatory receptor CD28 in the mouse.
    Gross JA; Callas E; Allison JP
    J Immunol; 1992 Jul; 149(2):380-8. PubMed ID: 1320641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in responsiveness to CD3 stimulation between naive and memory CD4+ T cells cannot be overcome by CD28 costimulation.
    Kuiper H; Brouwer M; de Boer M; Parren P; van Lier RA
    Eur J Immunol; 1994 Sep; 24(9):1956-60. PubMed ID: 7522154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.